Global Intranasal Drug Delivery Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Intranasal Drug Delivery Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Intranasal Drug Delivery Devices is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis.

Market Overview:

The latest research study on the global Intranasal Drug Delivery Devices market finds that the global Intranasal Drug Delivery Devices market reached a value of USD 1304.99 million in 2022. It’s expected that the market will achieve USD 2265.59 million by 2028, exhibiting a CAGR of 9.63% during the forecast period.

Strength

Needle- free application mode.
The permeable application site in the nasal cavity.
A rapid onset of local and systemic drug actions.
Development of economy and technology.

Weakness

The limited area (150 cm2) in the nasal cavity.
The tissue is vulnerable.
Suitable for invasive drugs.

Opportunity

Delivery device with higher drug utilization efficiency.
People increase demanding high medical technology.
Rapid development of the medical base in developing countries.

Threat

Product substitution in emerging markets.
Unbalanced regional development.
Development of other drug delivery technologies.

Region Overview:

From 2022-2027, North America is estimated to witness robust growth prospects.

Company Overview:

BD Medical is one of the major players operating in the Intranasal Drug Delivery Devices market, holding a share of 27.83% in 2020.

BD Medical

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

3M

3M is a global science company that never stops inventing. Their inventions have improved daily life for hundreds of millions of people all over the world. With M USD32 billion in sales, its 91,000 employees connect with customers all around the world.

Segmentation Overview:

By type, Multidose segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Hospital Use segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Intranasal Drug Delivery Devices market covered in Chapter 3:

Bespak
3M
AptarGroup
NasoNeb, Inc.
Mystic Pharmaceuticals
H&T Presspart
Kurve Technology
Alchemy Pharmatech
Teleflex
OptiNose
SNBL
BD Medical

In Chapter 4 and Chapter 14.2, on the basis of types, the Intranasal Drug Delivery Devices market from 2018 to 2029 is primarily split into:

Multidose
Bidose
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Intranasal Drug Delivery Devices market from 2018 to 2029 covers:

Personal Use
Hospital Use

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)